![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Bussone Gennaro Allais Gianni Castagnoli Gabellari Ilaria Benedetto Chiara
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.12, Iss.12, 2011-08, pp. : 1933-1943
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Spotlight on Almotriptan in Migraine
By Keam S.J. Goa K.L. Figgitt D.P.
CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Almotriptan cost beneficial for migraine in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Almotriptan: aiming for early treatment in migraine
Inpharma, Vol. 1, Iss. 1486, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Almotriptan: A Review of its Use in Migraine
By Keam S.J. Goa K.L. Figgitt D.P.
Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Early almotriptan intervention ameliorates migraine symptoms
Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. :